
Pubmed-entry ::= {
  pmid 31301304,
  medent {
    em std {
      year 2019,
      month 7,
      day 14,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Skullcapflavone I suppresses proliferation of human lung cancer
 cells via down-regulating microRNA-21."
      },
      authors {
        names std {
          {
            name ml "Yang Y",
            affil str "Emergency Department, Shengli Oilfield Central
 Hospital, Dongying 257000, China."
          },
          {
            name ml "An R",
            affil str "Department of Respiratory Medicine, Shengli Oilfield
 Central Hospital, Dongying 257000, China."
          },
          {
            name ml "Feng T",
            affil str "Department of Respiratory Medicine, Shengli Oilfield
 Central Hospital, Dongying 257000, China."
          },
          {
            name ml "Qin X",
            affil str "Emergency Department, Shengli Oilfield Central
 Hospital, Dongying 257000, China."
          },
          {
            name ml "Zhang J",
            affil str "Department of Respiratory Medicine, Shengli Oilfield
 Central Hospital, Dongying 257000, China."
          },
          {
            name ml "Bo Y",
            affil str "Emergency Department, Shengli Oilfield Central
 Hospital, Dongying 257000, China."
          },
          {
            name ml "Niu B",
            affil str "Department of Respiratory Medicine, Shengli Oilfield
 Central Hospital, Dongying 257000, China. Electronic address:
 123niuben@sina.com."
          }
        }
      },
      from journal {
        title {
          iso-jta "Exp. Mol. Pathol.",
          ml-jta "Exp Mol Pathol",
          issn "1096-0945",
          name "Experimental and molecular pathology"
        },
        imp {
          date std {
            year 2019,
            month 10
          },
          volume "110",
          pages "104285",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2018,
                month 12,
                day 4
              }
            },
            {
              pubstatus revised,
              date std {
                year 2019,
                month 7,
                day 1
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2019,
                month 7,
                day 10
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2019,
                month 7,
                day 14,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2020,
                month 2,
                day 26,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2019,
                month 7,
                day 14,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 31301304,
        pii "S0014-4800(18)30587-2",
        doi "10.1016/j.yexmp.2019.104285",
        other {
          db "ELocationID pii",
          tag str "S0014-4800(18)30587-2"
        },
        other {
          db "ELocationID doi",
          tag str "10.1016/j.yexmp.2019.104285"
        }
      }
    },
    abstract "BACKGROUND: Lung cancer is the most leading cause of
 cancer-related deaths worldwide. Skullcapflavone I is a flavone compound
 extracted from Scutellaria baicalensis Georgi (Wogon). The present study
 investigated the effects of skullcapflavone I on human lung cancer cell
 proliferation, as well as underlying possible mechanism. METHODS: Cell
 proliferation was detected using Trypan blue assay. Cell viability was
 measured using cell counting kit 8 (CCK-8) assay. Quantitative reverse
 transcription PCR (qRT-PCR) was performed to assess microRNA-21 (miR-21)
 expression. Cell transfection was conducted to enhance the levels of miR-21
 and protein phosphatase 2A (PP2A). Western blotting was used to evaluate the
 expressions of proliferation cell nuclear antigen (PCNA), Cyclin D1, PP2A,
 phosphatidylinositol 3-kinase (PI3K), protein kinase 3 (AKT), mechanistic
 target of rapamycin (mTOR) and p70S6K. RESULTS: Skullcapflavone I
 significantly suppressed the viability and proliferation of A549 and H1975
 cells. The expressions of miR-21 in A549 and H1975 cells were drastically
 decreased after skullcapflavone I treatment. Overexpression of miR-21
 remarkably reversed the skullcapflavone I-induced A549 cell viability
 inhibition. Moreover, skullcapflavone I enhanced the expression of PP2A in
 A549 cells. Skullcapflavone I inactivated PI3K/AKT/mTOR signaling pathway in
 A549 cells via up-regulating PP2A. Besides, skullcapflavone I treatment had
 no significant influence on human normal bronchial epithelial 16HBE cell
 viability, proliferation and apoptosis. CONCLUSION: Skullcapflavone I exerted
 anti-cancer effect on lung cancer cells by down-regulating miR-21 expression,
 up-regulating PP2A expression and then inactivating PI3K/AKT/mTOR signaling
 pathway.",
    mesh {
      {
        term "A549 Cells"
      },
      {
        term "Cell Line"
      },
      {
        term "Cell Line, Tumor"
      },
      {
        term "Cell Proliferation",
        qual {
          {
            mp TRUE,
            subh "drug effects"
          },
          {
            subh "genetics"
          }
        }
      },
      {
        term "Cell Survival",
        qual {
          {
            subh "drug effects"
          },
          {
            subh "genetics"
          }
        }
      },
      {
        term "Down-Regulation",
        qual {
          {
            mp TRUE,
            subh "drug effects"
          },
          {
            subh "genetics"
          }
        }
      },
      {
        term "Flavones",
        qual {
          {
            mp TRUE,
            subh "pharmacology"
          }
        }
      },
      {
        term "Gene Expression Regulation, Neoplastic",
        qual {
          {
            mp TRUE,
            subh "drug effects"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Lung Neoplasms",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "metabolism"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "MicroRNAs",
        qual {
          {
            mp TRUE,
            subh "genetics"
          }
        }
      },
      {
        term "Phosphatidylinositol 3-Kinases",
        qual {
          {
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Protein Phosphatase 2",
        qual {
          {
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Proto-Oncogene Proteins c-akt",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Signal Transduction",
        qual {
          {
            subh "drug effects"
          },
          {
            subh "genetics"
          }
        }
      },
      {
        term "TOR Serine-Threonine Kinases",
        qual {
          {
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Flavones"
      },
      {
        type nameonly,
        name "MIRN21 microRNA, human"
      },
      {
        type nameonly,
        name "MicroRNAs"
      },
      {
        type cas,
        cit "8P86A8Q1G0",
        name "skullcapflavone I"
      },
      {
        type ec,
        cit "2.7.1.1",
        name "MTOR protein, human"
      },
      {
        type ec,
        cit "2.7.1.1",
        name "TOR Serine-Threonine Kinases"
      },
      {
        type ec,
        cit "2.7.11.1",
        name "Proto-Oncogene Proteins c-akt"
      },
      {
        type ec,
        cit "3.1.3.16",
        name "Protein Phosphatase 2"
      }
    },
    pmid 31301304,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}


